IL-12- and IL-18-mediated, nitric oxide-induced apoptosis in TNF-α-mediated osteoclastogenesis of bone marrow cells

Calcified Tissue International

Volumn 89, Issue 1, 2011, Pages 65-73

  Kitaura, Hideki ^a   Fujimura, Yuji ^b   Yoshimatsu, Masako ^b   Kohara, Haruka ^b   Morita, Yukiko ^b   Aonuma, Tomo ^a   Fukumoto, Emiko ^a   Masuyama, Ritsuko ^b   Yoshida, Noriaki ^b   Takano Yamamoto, Teruko ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Apoptosis; IL 12; IL 18; Nitric oxide; Osteoclast; TNF

Indexed keywords

COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 18; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL ADHESION; CELL CULTURE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; UPREGULATION;

ANIMALS; APOPTOSIS; BONE MARROW CELLS; INTERLEUKIN-12; INTERLEUKIN-18; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OSTEOCLASTS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 79959771114     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-011-9494-0     Document Type: Article

References (38)

1. Teitelbaum SL (2000) Bone resorption by osteoclasts. Science 289:1504-1508
2. Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin TJ, Suda T (2000) Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 191:275-286
3. Kim N, Kadono Y, Takami M, Lee J, Lee SH, Okada F, Kim JH, Kobayashi T, Odgren PR, Nakano H, Yeh WC, Lee SK, Lorenzo JA, Choi Y (2005) Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J Exp Med 202:589-595 (Pubitemid 41248411)
4. Kitaura H, Sands MS, Aya K, Zhou P, Hirayama T, Uthgenannt B, Wei S, Takeshita S, Novack DV, Silva MJ, Abu AY, Ross FP, Teitelbaum SL (2004) Marrow stromal cells and osteoclast precursors differentially contribute to TNF-alpha-induced osteoclastogenesis in vivo. J Immunol 173:4838-4846 (Pubitemid 39387764)
5. Kitaura H, Zhou P, Kim HJ, Novack DV, Ross FP, Teitelbaum SL (2005) M-CSF mediates TNF-induced inflammatory osteolysis. J Clin Invest 115:3418-3427 (Pubitemid 43121830)
6. Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL (2000) TNF-a induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106:1481-1488 (Pubitemid 32038586)
7. Tracey KJ, Cerami A (1993) Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 9:317-343
8. Wong M, Ziring D, Korin Y, Desai S, Kim S, Lin J, Gjertson D, Braun J, Reed E, Singh RR (2008) TNF-a blockade in human diseases: mechanisms and future directions. Clin Immunol 126: 121-136
9. Berenson LS, Ota N, Murphy KM (2004) Issues in T-helper 1 development - resolved and unresolved. Immunol Rev 202:157-174 (Pubitemid 39576911)
10. Scott P (1993) IL-12: initiation cytokine for cell-mediated immunity. Science 260:496-497
11. Bost KL, Ramp WK, Nicholson NC, Bento JL, Marriott I, Hudson MC (1999) Staphylococcus aureus infection of mouse or human osteoblasts induces high levels of interleukin-6 and interleukin-12 production. J Infect Dis 180:1912-1920
12. Okamura H, Tsutsui H, Kashiwamura S, Yoshimoto T, Nakanishi K (1998) Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv Immunol 70:281-312 (Pubitemid 128678839)
13. Udagawa N, Horwood NJ, Elliott J, Mackay A, Owens J, Okamura H, Kurimoto M, Chambers TJ, Martin TJ, Gillespie MT (1997) Interleukin-18 (interferon-γ-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colonystimulating factor and not via interferon-γ to inhibit osteoclast formation. J Exp Med 185:1005-1012 (Pubitemid 27136793)
14. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K, Akita K, Namba M, Tanabe F, Konishi K, Fukuda S, Kurimoto M (1995) Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 378:88-91
15. Nagata N, Kitaura H, Yoshida N, Nakayama K (2003) Inhibition of RANKL-induced osteoclast formation in mouse bone marrow cells by IL-12: involvement of IFN-γ possibly induced from non- T cell population. Bone 33:721-732 (Pubitemid 37222399)
16. Kitaura H, Nagata N, Fujimura Y, Hotokezaka H, Yoshida N, Nakayama K (2002) Effect of IL-12 on TNF-α-mediated osteoclast formation in bone marrow cells: apoptosis mediated by Fas/ Fas ligand interaction. J Immunol 169:4732-4738 (Pubitemid 35217134)
17. Yoshimatsu M, Kitaura H, Fujimura Y, Eguchi T, Kohara H, Morita Y, Yoshida N (2009) IL-12 inhibits TNF-alpha induced osteoclastogenesis via a T cell-independent mechanism in vivo. Bone 45:1010-1016
18. Kitaura H, Tatamiya M, Nagata N, Fujimura Y, Eguchi T, Yoshida N, Nakayama K (2006) IL-18 induces apoptosis of adherent bone marrow cells in TNF-α mediated osteoclast formation in synergy with IL-12. Immunol Lett 107:22-31 (Pubitemid 44332544)
19. Morita Y, Kitaura H, Yoshimatsu M, Fujimura Y, Kohara H, Eguchi T, Yoshida N (2010) IL-18 inhibits TNF-alpha-induced osteoclastogenesis possibly via a T cell-independent mechanism in synergy with IL-12 in vivo. Calcif Tissue Int 86:242-248
20. Kroncke KD, Fehsel K, Suschek C, Kolb BV (2001) Inducible nitric oxide synthase-derived nitric oxide in gene regulation, cell death and cell survival. Int Immunopharmacol 1:1407-1420 (Pubitemid 32622787)
21. MacIntyre I, Zaidi M, Alam AS, Datta HK, Moonga BS, Lidbury PS, Hecker M, Vane JR (1991) Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP. Proc Natl Acad Sci USA 88:2936-2940 (Pubitemid 21916535)
22. Lowik CW, Nibbering PH, Ruit M, Papapoulos SE (1994) Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption. J Clin Invest 93:1465-1472 (Pubitemid 24116382)
23. Dinarello CA (1999) IL-18: a TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 103:11-24
24. Parfitt AM, Mundy GR, Roodman GD, Hughes DE, Boyce BF (1996) A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates. J Bone Miner Res 11:150-159 (Pubitemid 26054173)
25. Brandi ML, Hukkanen M, Umeda T, Moradi BN, Bianchi S, Gross SS, Polak JM, MacIntyre I (1995) Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms. Proc Natl Acad Sci USA 92:2954-2958
26. Ralston SH, Grabowski PS (1996) Mechanisms of cytokine induced bone resorption: role of nitric oxide, cyclic guanosine monophosphate, and prostaglandins. Bone 19:29-33 (Pubitemid 26318741)
27. Collin OP, Rothe L, Bekker S, Anderson F, Osdoby P (2000) Decreased nitric oxide levels stimulate osteoclastogenesis and bone resorption both in vitro and in vivo on the chick chorioallantoic membrane in association with neoangiogenesis. J Bone Miner Res 15:474-488 (Pubitemid 30134092)
28. Ralston SH, Ho LP, Helfrich MH, Grabowski PS, Johnston PW, Benjamin N (1995) Nitric oxide: a cytokine-induced regulator of bone resorption. J Bone Miner Res 10:1040-1049
29. Kanaoka K, Kobayashi Y, Hashimoto F, Nakashima T, Shibata M, Kobayashi K, Kato Y, Sakai H (2000) A common downstream signaling activity of osteoclast survival factors that prevent nitric oxide-promoted osteoclast apoptosis. Endocrinology 141:2995-3005 (Pubitemid 32250464)
30. Lee SK, Huang H, Lee SW, Kim KH, Kim KK, Kim HM, Lee ZH, Kim HH (2004) Involvement of iNOS-dependent NO production in the stimulation of osteoclast survival by TNF-alpha. Exp Cell Res 298:359-368 (Pubitemid 38950854)
31. Ralston SH, Todd D, Helfrich M, Benjamin N, Grabowski PS (1994) Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. Endocrinology 135:330-336 (Pubitemid 24203834)
32. Nussler AK, Di SM, Billiar TR, Hoffman RA, Geller DA, Selby R, Madariaga J, Simmons RL (1992) Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med 176:261-264
33. Grabowski PS, Macpherson H, Ralston SH (1996) Nitric oxide production in cells derived from the human joint. Br J Rheumatol 35:207-212
34. Zheng H, Yu X, Collin OP, Osdoby P (2006) RANKL stimulates inducible nitric-oxide synthase expression and nitric oxide production in developing osteoclasts. An autocrine negative feedback mechanism triggered by RANKL-induced interferon-beta via NF-kappaB that restrains osteoclastogenesis and bone resorption. J Biol Chem 281:15809-15820 (Pubitemid 43848471)
35. Ahn HJ, Maruo S, Tomura M, Mu J, Hamaoka T, Nakanishi K, Clark S, Kurimoto M, Okamura H, Fujiwara H (1997) A mechanism underlying synergy between IL-12 and IFN-γ-inducing factor in enhanced production of IFN-γ. J Immunol 159:2125-2131 (Pubitemid 127681000)
36. - cells. J Immunol 160:4738-4746
37. + T lymphocytes. J Immunol 160:3642-3647
38. Horwood NJ, Elliott J, Martin TJ, Gillespie MT (2001) IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro. J Immunol 166:4915-4921 (Pubitemid 32280701)